Innate Biotherapeutics
Pre-clinicalInnate Biotherapeutics is a biotech company developing immunotherapies that convert the immunosuppressive tumor microenvironment into an immunostimulatory one, by activating both innate and adaptive immune cells, and thus selectively treat a wide range of tumor types.
Founded
2016
Focus
AntibodiesBiologicsSmall Molecules
About
Innate Biotherapeutics is a biotech company developing immunotherapies that convert the immunosuppressive tumor microenvironment into an immunostimulatory one, by activating both innate and adaptive immune cells, and thus selectively treat a wide range of tumor types.
Funding History
1Total raised: $15M
Series A$15MF-Prime CapitalSep 15, 2020
Company Info
TypePrivate
Founded2016
LocationSeattle, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile